Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06EQP
|
||||
| Former ID |
DAP001075
|
||||
| Drug Name |
Aceprometazine
|
||||
| Synonyms |
Aceprometazina; Aceprometazinum; Acepromethazine; Aceprometazina [INN-Spanish]; Aceprometazine [INN:DCF]; Aceprometazinum [INN-Latin]; Mepronizine (TN); KETONE, 10-(2-(DIMETHYLAMINO)PROPYL)PHENOTHIAZIN-2-YL METHYL; Ethanone, 1-(10-(2-(dimethylamino)propyl)-10H-phenothiazin-2-yl)-(9CI); 1-(10-(2-(Dimethylamino)propyl)-10H-phenothiazin-2-yl)ethanone; 1-[10-[2-(dimethylamino)propyl]phenothiazin-2-yl]ethanone; 1-{10-[2-(dimethylamino)propyl]-10H-phenothiazin-2-yl}ethanone; 10-(2-(Dimethylamino)propyl)phenothiazin-2-yl methyl ketone; 1664 CB
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Sleep disorders [ICD9: 307.4, 327, 780.5; ICD10:F51, G47] | Approved | [550730] | ||
| Therapeutic Class |
Antihistamines
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H22N2OS
|
||||
| Canonical SMILES |
CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(=O)C)N(C)C
|
||||
| InChI |
1S/C19H22N2OS/c1-13(20(3)4)12-21-16-7-5-6-8-18(16)23-19-10-9-15(14(2)22)11-17(19)21/h5-11,13H,12H2,1-4H3
|
||||
| InChIKey |
XLOQNFNTQIRSOX-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 13461-01-3
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Histamine H1 receptor | Target Info | Antagonist | [536284] | |
| PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.